Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells Activity

Full-text?

The full document isn't yet available to us from the patent office, but we've found a related patent (family member) to use for our images and PDF.

Abstract

The invention relates to antibodies against human CD39 and use thereof for inhibiting T regulatory cells (Treg) activity. More particularly CD39 antibodies may be used for the treatment or prevention of cancers and infectious diseases.


Claims

Information currently unavailable.

Family Member PDF
Family Member Preview
These are the images from a related family member, as the full document isn't yet available to us from the patent office.
Document History
  • Publication: Aug 6, 2009
  • Application: Jan 30, 2009
    WO EP 2009051078 W
  • Priority: Aug 20, 2008
    EP EP 08162683 A
  • Priority: Jan 31, 2008
    EP EP 08300061 A

Download Citation


Sign in to the Lens

Feedback